computational modeling of drug disposition(modeling techniques, solubility, intestinal permeation, drug distribution, drug excretion, active transporter, P-gp, BCRP, Nucleoside transporter, HPEPTI, ASBT, OCT, OATP, BBB
KavyasriPuttamreddy
39 views
12 slides
Nov 20, 2024
Slide 1 of 12
1
2
3
4
5
6
7
8
9
10
11
12
About This Presentation
computational modeling of drug disposition , modeling techniques: qualitative &quantitative approaches
drug absorption, solubility, drug disposition, modeling techniques, solubility, intestinal permeation, drug distribution, drug excretion, active transporter, P-gp(P-glycoprotein), BCRP(Brest ca...
computational modeling of drug disposition , modeling techniques: qualitative &quantitative approaches
drug absorption, solubility, drug disposition, modeling techniques, solubility, intestinal permeation, drug distribution, drug excretion, active transporter, P-gp(P-glycoprotein), BCRP(Brest cancer resistance protein), Nucleoside transporter, HPEPTI(human peptide transporter), ASBT(Apical sodium dependend bile acid transporter), OCT(organic cation transporters), OATP(organic anion transporting polypeptides), BBB(Blood Brain barrier choline transporter)
Size: 22.6 MB
Language: en
Added: Nov 20, 2024
Slides: 12 pages
Slide Content
CG ret tonal dino + da
fa Un 4 Computational rvalebrq sto antici nite
Chemical dk, preto Compawdo Shin ling.
a Con Seip Y Wu drug disco, recio
| vaio : melti
(Gas bat
» ou N Yiderulordyramid,
Sn \
Ne ad IT
Qusthe -bioed
ane melt
Combred mabtaly |
Modelling 9 Tec Fmiopan? -
The ana 2 raion approche dj the do éd.
mig) > me
gt Be Mer prodeling
» flexible Ak Studi,
basofipl a Sula 08 SS) fa
ideas y blo Snap § Nea galo Bat One saline
in ADH) Proc
grd Shruual
un) harten
The ag id” à diera Glevible eckig 2
¿Jin doug dixes hos recon bain ei
rademdened fron Utter i hin
Re ou Tan in Bully doug ADN
pepe . Ê
Yuaktaki x Opprahh:
ls Nepencicty eu QSAR ( Whe )
Structure adhivity vélationÿhip). E
OSPR ( iasbilin Stücke
En
Genevat
predict “Ke Sdubli 4 Congo Quen bef
Syrian 4 E, Ge “as b
Q Oppeadus di Soli
xd En the Und
Ewmplrical apy h
pil approach.
a
perked by GSPR 1 lid mubivanda
av
Ly do Mealy €
Mu € Sobabilth, .
target popaly fa mat Me is
A ra
Iahen, blu maloalar
doc
- ba abilih, q Ags Y
Separating Hu qu
The precoz \nvdoe Pas diffuse £
s-Acive banppdt
+ Conpler meca, Eat 4 difficult to peda
eculon __mickaniime
Solel, bad en 4
— Mot Groot. model» Cima ‘to
ADOC, PAMPR stich,
Desumection ex (a
have bam led dndkat 4 In vive dl
à. t value alo helyol fs
molec ib cue TA
predid tha Cl
Or dist bufion :
img pram
-(Gndual 5 Ph Cochon Pope Y
Gekimine tee bet ik di
Yraduunveflescted y pra
deer
Jin
¥Hepotic main
Componorily . 6} Plame (Clearance
medal hay Daun Ml.
A y
Ar Lise eo sehen +
TITLE Mapa :
Tentes chota be om intel Pat 9 ory
ADMET madelling Pere because of thas
pio me En PIM Mim ¢ Ke
Substoiiel ovalen Hy “tien Ould
de
Unir Becas of kind Eno sae ara
mer pedid” a À
“+
— Response {à
Become
Uheckive
ep
dant y Let
hay beceme
~ e bo)
huchequn bend ACCESO
Mu Dama Faluy a
Em ehie Cup o,
ay. Yo
mac, Stu
aposimuctal. data
PAR
o be
Faded Numb,
ton
brain ¡Puso invpli cling ik
ds pr En Doha
— Modul Emprodiz ven 4
Joona Yequivenedd q
the Bat dsuble bed ur
= Ne u Pe be, (seuld Vendas
Compound Surraptible to BeRP > but not
ito who ta malt dea hat recedasly bocha h
Ds Candidate fen BCRP harpatt.
=
beta,
Cr dal
ic TPS
hy |
1 hyd
1
hat, bound dé
gén bamd oC ents)
Fu tenable Heokusa
A 3,8 " (agi Bodin ependond buy,
Re OLid Sonya)
A gl unit, Que Capaz Var)
En la apical. membrane Latin
5 Chalangie y (et cu st Eu
U ais obra, oh bile Qaida ¢ Vs
An, te Proideng an additional
Weitical forget qe prog chug ahapti
IT dal vost SED “Fringe
8 hydrphobiccestay
Vegan bond dena .
UNS den bond ÓN